Literature DB >> 19250962

Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease.

R Thangavel1, S K Sahu, G W Van Hoesen, A Zaheer.   

Abstract

The distribution of immunoreactive neurons with nonphosphorylated neurofilament protein (SMI32) was studied in temporal cortical areas in normal subjects and in patients with Alzheimer's disease (AD). SMI32 immunopositive neurons were localized mainly in cortical layers II, III, V and VI, and were medium to large-sized pyramidal neurons. Patients with AD had prominent degeneration of SMI32 positive neurons in layers III and V of Brodmann areas 38, 36, 35 and 20; in layers II and IV of the entorhinal cortex (Brodmann area 28); and hippocampal neurons. Neurofibrillary tangles (NFTs) were stained with Thioflavin-S and with an antibody (AT8) against hyperphosphorylated tau. The NFT distribution was compared to that of the neuronal cytoskeletal marker SMI32 in these temporal cortical regions. The results showed that the loss of SMI32 immunoreactivity in temporal cortical regions of AD brain is paralleled by an increase in NFTs and AT8 immunoreactivity in neurons. The SMI32 immunoreactivity was drastically reduced in the cortical layers where tangle-bearing neurons are localized. A strong SMI32 immunoreactivity was observed in numerous neurons containing NFTs by double-immunolabeling with SMI32 and AT8. However, few neurons were labeled by AT8 and SMI32. These results suggest that the development of NFTs in some neurons results from some alteration in SMI32 expression, but does not account for all, particularly, early NFT-related changes. Also, there is a clear correlation of NFTs with selective population of pyramidal neurons in the temporal cortical areas and these pyramidal cells are specifically prone to formation of paired helical filaments. Furthermore, these pyramidal neurons might represent a significant portion of the neurons of origin of long corticocortical connection, and consequently contribute to the destruction of memory-related input to the hippocampal formation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19250962      PMCID: PMC2669695          DOI: 10.1016/j.neuroscience.2009.02.037

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  37 in total

Review 1.  The selective vulnerability of nerve cells in Huntington's disease.

Authors:  K A Sieradzan; D M Mann
Journal:  Neuropathol Appl Neurobiol       Date:  2001-02       Impact factor: 8.090

2.  Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.

Authors:  C E Shepherd; E Thiel; H McCann; G M Halliday
Journal:  Neurobiol Dis       Date:  2001-02       Impact factor: 5.996

3.  Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease.

Authors:  P Giannakopoulos; F R Herrmann; T Bussière; C Bouras; E Kövari; D P Perl; J H Morrison; G Gold; P R Hof
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

4.  Pyramidal cell loss in motor cortices in Huntington's disease.

Authors:  Virginia Macdonald; Glenda Halliday
Journal:  Neurobiol Dis       Date:  2002-08       Impact factor: 5.996

5.  Neuronal loss and neurofibrillary degeneration in the hippocampal cortex in late-onset sporadic Alzheimer's disease.

Authors:  Y Fukutani; N J Cairns; M Shiozawa; K Sasaki; S Sudo; K Isaki; P L Lantos
Journal:  Psychiatry Clin Neurosci       Date:  2000-10       Impact factor: 5.188

6.  Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

Authors:  Jean C Augustinack; Anja Schneider; Eva-Maria Mandelkow; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2002-01       Impact factor: 17.088

7.  Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease.

Authors:  Thomas W Mitchell; Elliott J Mufson; Julie A Schneider; Elizabeth J Cochran; Jonathan Nissanov; Li-Ying Han; Julia L Bienias; Virginia M -Y Lee; John Q Trojanowski; David A Bennett; Steven E Arnold
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

8.  Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease.

Authors:  T Bussière; G Gold; E Kövari; P Giannakopoulos; C Bouras; D P Perl; J H Morrison; P R Hof
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

Review 9.  Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease.

Authors:  John H Morrison; Patrick R Hof
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

10.  Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.

Authors:  Angela L Guillozet; Sandra Weintraub; Deborah C Mash; M Marsel Mesulam
Journal:  Arch Neurol       Date:  2003-05
View more
  26 in total

1.  Augmented expression of glia maturation factor in Alzheimer's disease.

Authors:  S Zaheer; R Thangavel; S K Sahu; A Zaheer
Journal:  Neuroscience       Date:  2011-08-02       Impact factor: 3.590

2.  The contributions of MRI-based measures of gray matter, white matter hyperintensity, and white matter integrity to late-life cognition.

Authors:  J He; V S S Wong; E Fletcher; P Maillard; D Y Lee; A-M Iosif; B Singh; O Martinez; A E Roach; S N Lockhart; L Beckett; D Mungas; S T Farias; O Carmichael; C DeCarli
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-26       Impact factor: 3.825

3.  Efficient down-regulation of glia maturation factor expression in mouse brain and spinal cord.

Authors:  Smita Zaheer; Yanghong Wu; Xi Yang; Ramasamy Thangavel; Shailendra K Sahu; Asgar Zaheer
Journal:  Neurochem Res       Date:  2012-03-25       Impact factor: 3.996

4.  Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ.

Authors:  Parvathi Rudrabhatla; Philip Grant; Howard Jaffe; Michael J Strong; Harish C Pant
Journal:  FASEB J       Date:  2010-07-12       Impact factor: 5.191

5.  Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease.

Authors:  R Thangavel; D Stolmeier; X Yang; P Anantharam; A Zaheer
Journal:  Neuropathol Appl Neurobiol       Date:  2012-10       Impact factor: 8.090

6.  Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.

Authors:  Ramasamy Thangavel; Sachin M Bhagavan; Swathi Beladakere Ramaswamy; Spurthi Surpur; Raghav Govindarajan; Duraisamy Kempuraj; Smita Zaheer; Sudhanshu Raikwar; Mohammad E Ahmed; Govindhasamy Pushpavathi Selvakumar; Shankar S Iyer; Asgar Zaheer
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Glia maturation factor expression in entorhinal cortex of Alzheimer's disease brain.

Authors:  Ramasamy Thangavel; Duraisamy Kempuraj; Deirdre Stolmeier; Poojya Anantharam; Mohammad Khan; Asgar Zaheer
Journal:  Neurochem Res       Date:  2013-05-29       Impact factor: 3.996

Review 8.  Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta.

Authors:  Heng Du; Shirley ShiDu Yan
Journal:  Biochim Biophys Acta       Date:  2009-07-16

Review 9.  Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders.

Authors:  Aidong Yuan; Ralph A Nixon
Journal:  Brain Res Bull       Date:  2016-09-05       Impact factor: 4.077

10.  Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol.

Authors:  Mohammad Moshahid Khan; Duraisamy Kempuraj; Ramasamy Thangavel; Asgar Zaheer
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.